Gene · 23607
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
681 to 700 of 1,872
Download this page as JSON| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| R01MH087950 | BAR PROTEINS LINKING MEMBRANE AND CYTOSKELETON DYNAMICS | 1 | 2020 |
| R01MH109706 | Linking Ciliary Biology to the Functional Annotation of Psychiatric Distorders | 1 | 2020 |
| R01NS095922 | MicroRNA modulation of tau expression and phosphorylation in tauopathy | 1 | 2020 |
| R01NS098769 | The degradation of tau by selective autophagy | 1 | 2020 |
| R01NS099125 | Mechanisms of the recognition of degenerating dendrites | 1 | 2020 |
| R21AG061551 | Novel misfolded proteins in ADRD: proteomics, genetics, and clinical-pathological correlations | 1 | 2020 |
| R21AG066865 | Pumping iron: Loss of iron homeostasis causes microglia degeneration in AD | 1 | 2020 |
| R21AG067016 | A personalized medicine approach to the study of monoamine brain systems that underlie the emergence of neuropsychiatric symptoms in person with Alzheimer's disease | 1 | 2020 |
| R21NS118891 | The role of autophagy in the neurovascular unit for the physiological response to stress. | 1 | 2020 |
| R24DK082841 | Integrated Systems Biology Approach to Diabetic Microvascular Complications | 1 | 2020 |
| R56AG057191 | Genomic Architecture of a Key Alzheimer's Disease Mimic: CARTS | 1 | 2020 |
| R56AG066889 | Whole genome sequencing of the Mexican Health Aging Study (MHAS) cohort | 1 | 2020 |
| R56AG067739 | BAG3 as a proteostatic hub regulating neuronal health | 1 | 2020 |
| R56AG069118 | Genetic and environmental risk factors in mestizos and indigenous populations of Peru: the role of Native component in Alzheimer's disease | 1 | 2020 |
| RF1AG063481 | Advancing Analysis of Multi-omics Data in Alzheimer's Disease Research | 1 | 2020 |
| RF1AG071170 | Quantitative Genetic Models for Exploring Missing Heritability of Alzheimer's Disease | 1 | 2020 |
| RF1NS117446 | Cell and Molecular Consequences of Alzheimer's Disease Genetic Variants on BBB Integrity and Function | 1 | 2020 |
| RF1NS118584 | Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification | 1 | 2020 |
| T32GM007197 | Genetics and Regulation | 1 | 2020 |
| T32GM008554 | Cellular, Biochemical and Molecular Sciences Training Program | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/grants?page=35